JAMA at Kidney Week, JAMA Summit Report on Firearm Violence Reduction, AI for Drug Discovery, and more
JAMA Editors' Summary
00:00
SGLT2 Inhibitors Benefit CKD Regardless of Diabetes
Preeti reviews meta-analyses showing SGLT2 inhibitors reduce kidney outcomes, hospitalization, and mortality across eGFR and albuminuria levels.
Play episode from 03:28
Transcript
